In this SelectScience webinar, Dr. Jose Alexander, Director - Clinical Microbiologist at AdventHealth Orlando, will discuss two key considerations when tackling the pressing issue of multidrug-resistant organisms.
The first is looking at resistance mechanisms with an emphasis on beta-lactamases and how they are evolving. Key questions include:
The second half of the presentation will focus on time to effective therapy asking, “What is the impact on patient outcomes and the true cost of therapy (length of stay (LOS), duration of therapy (DOT), antibiotic (ABX) days) when prescribing ineffective treatment?”
Alexander will present an example of an infection and two drug options, e.g. Cefidericol (a new drug launching in Q1 2020) vs. an existing antibiotic, e.g. carbapenem.
Join us live on Monday, January 27, at 16:00 GMT | 17:00 CET |11:00 EST | 08:00 PST:
All webinar participants can request a certificate of attendance, and a learning outcomes summary document for continuing education purposes.
Watch this webinar to:
Who should attend?
Scheduling conflict? Don’t worry, register to receive an on-demand link to watch later>>